The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So one of the major prescription omega-3s out there is, both of them actually, Lovaza, which is a mixture of DHA and EPA, as well as Vascepa, which is a highly purified EPA. These are both prescribed by physicians to patients with hypertriglyceridemia, so high triglycerides among other things, I think maybe dysregulation of lipids as well.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
what's called Lovaza and it's now about 85% epa plus DHA it's ethyl esters
only vasepa is indicated for people for reducing risk for cardiovascular events because it's the only one that's been shown to do that lavaze has never been tested for lowering cardiovascular events it's the epa plus dha product but it's approved for triglyceride lowering
laveza is the epa plus dha ethyl ester uh vasipa is an epa-only athlester